Skip to main content
. Author manuscript; available in PMC: 2013 May 18.
Published in final edited form as: J Mol Biol. 2012 Mar 3;418(5):367–378. doi: 10.1016/j.jmb.2012.02.024

Figure 5.

Figure 5

DTT-treatment diminishes responses of disulfide-containing constitutive alleles to the α-factor analog dTA that activates constitutive receptors but behaves as an antagonist toward normal receptors. Where indicated, cells were treated with 0.5 mM DTT for 2 hours prior to the addition of dTA.